E-EVs have been proposed to serve as a biomarker for arterial stiffness in pediatric HD patients, as pulse wave velocity, an accepted measure of arterial stiffness, correlated with CD144+ e-EV levels that were higher in HD patients compared with non-HD controls [52]. The gene discussed is CDH5; the disease is Huntington disease.